Vida Solutions Blog
Field notes for life sciences commercial teams
Practical writing on revenue operations, data architecture, and AI workflow automation, from the operators who build the systems.
Why Your Medtech Forecast Is Always Wrong: A RevOps Fix That Does Not Require a New CRM
Your medtech forecast is off because reps define stages differently, not because your CRM is wrong. Fix the architecture, not the software.
Read article →
When Biotech Lays Off, Sales-Marketing Alignment Is the First Thing to Break. Here Is How to Rebuild It Fast.
Biotech layoffs break sales-marketing alignment fast. Here is how to rebuild handoffs, CRM ownership, and pipeline visibility with the team you have now.
Why Pipeline Governance Is the Missing Infrastructure in Life Sciences RevOps
Pipeline hygiene is not a governance discipline. If QBR prep means scrubbing the CRM the week before, you have a cleanup ritual, not governance.
Your Biotech GTM Launch Does Not Have a Marketing Problem. It Has a Handoff Problem.
Sales says marketing's leads go nowhere. Marketing says sales ignores them. The real problem is structural: it lives in your CRM and your handoff logic.
Beyond the Pilot: How Life Sciences RevOps Teams Finally Ship AI Agents to Production
The pilot worked and the demo impressed. Then legal asked about 21 CFR Part 11. Shipping AI agents is a deployment-framework problem, not a model problem.
The HIPAA-Ready Salesforce-to-Snowflake Blueprint Every Biotech RevOps Team Needs Before Due Diligence
Most biotech teams discover their Salesforce-to-Snowflake pipeline has a compliance problem only when a deal is already on the table. That gap is fixable.
How AI Agents Are Fixing Broken Pipeline Forecasting in Life Sciences RevOps
Your forecast is only as accurate as the last rep who updated their opportunities. The real forecasting problem is not data. It is signal latency.
What RevOps Maturity Level Is Your Life Sciences Company Actually At? (And What to Do Next)
Most growth-stage pharma and biotech teams think they have a forecasting problem. What they actually have is a maturity problem, and those need different fixes.
The 5 Salesforce Architecture Mistakes Quietly Killing Your Life Sciences GTM (And How to Fix Them)
You can have the right product, market, and team and still watch pipeline stall, because your CRM is lying to you. Not maliciously. Structurally.